{
    "body": "Which are the consequences of the hyperphosphorylated tau in Alzheimers' Disease?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23640887", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20942790", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10214944", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24448785", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22315694", 
        "http://www.ncbi.nlm.nih.gov/pubmed/7666054", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19459590", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22536363", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24965601", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17662457", 
        "http://www.ncbi.nlm.nih.gov/pubmed/11052669", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21715616", 
        "http://www.ncbi.nlm.nih.gov/pubmed/26258756", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9427351", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23340677", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15450610", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22203915", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9832145", 
        "http://www.ncbi.nlm.nih.gov/pubmed/7616230", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17372746", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16793187", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17906291", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23946388", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23805125", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25220759", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24788298", 
        "http://www.ncbi.nlm.nih.gov/pubmed/12214106", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19451179", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22110363", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19525898", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8960316", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25031639", 
        "http://www.ncbi.nlm.nih.gov/pubmed/9084440", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20678074"
    ], 
    "ideal_answer": [
        "The consequences of the hyperphosphorylated tau in Alzheimers' Disease is:\n1) The formation of neurofibrillary tangles (NFTs)\n2) Impaired glutamate metabolism\n3) Decreased tau affinity for microtubules binding\n4) Dendritic and axonal instability\n5) Synaptic degeneration\n6) Neuronal loss."
    ], 
    "exact_answer": [
        [
            "Neurofibrillary tangles formatio", 
            "NFTs", 
            "NFT formation"
        ], 
        [
            "Impaired glutamate metabolism"
        ], 
        [
            "Decreased affinity for microtubules binding"
        ], 
        [
            "Dendritic instability"
        ], 
        [
            "Axonal instability"
        ], 
        [
            "Synaptic degeneration"
        ], 
        [
            "Neuronal loss"
        ]
    ], 
    "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016875", 
        "http://www.uniprot.org/uniprot/TAU_HUMAN", 
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000544", 
        "http://www.disease-ontology.org/api/metadata/DOID:10652", 
        "http://www.uniprot.org/uniprot/TAU_MACMU", 
        "http://www.uniprot.org/uniprot/TAU_CAPHI", 
        "http://www.disease-ontology.org/api/metadata/DOID:1289"
    ], 
    "type": "list", 
    "id": "58a2efec60087bc10a000008", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 171, 
            "text": "The formation of neurofibrillary tangles from the assembly of hyperphosphorylated tau leads to dendritic and axonal instability, synaptic degeneration, and neuronal loss. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24448785", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 82, 
            "text": "Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23340677", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 190, 
            "text": "In neurodegenerative diseases including Alzheimer's disease and frontotemporal dementia, the protein tau is hyperphosphorylated and eventually aggregates to develop neurofibrillary tangles. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23340677", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 179, 
            "text": "Neurofibrillary tangles (NFTs), a marker of neuronal alterations in Alzheimer's disease (AD) and other tauopathies, are comprised of aggregates of hyperphosphorylated tau protein.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23946388", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 772, 
            "offsetInEndSection": 878, 
            "text": "At 24 months, NFTs progress, tau inclusions propagate to the dentate gyrus, and neuronal loss is evident. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23946388", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 372, 
            "offsetInEndSection": 554, 
            "text": "At autopsy, brains of AD and a subset of TBI victims display some similarities including accumulation of A\u03b2 peptides and neurofibrillary tangles of hyperphosphorylated tau proteins. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23805125", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 374, 
            "text": "The pathological hallmarks of Alzheimer's disease (AD)--widespread synaptic and neuronal loss and the pathological accumulation of amyloid-beta peptide (A\u03b2) in senile plaques, as well as hyperphosphorylated tau in neurofibrillary tangles--have been known for many decades, but the links between AD pathology and dementia and effective therapeutic strategies remain elusive. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22203915", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 179, 
            "text": "The microtubule-associated protein tau, in a hyperphosphorylated form, aggregates into insoluble paired-helical filaments (PHFs) in Alzheimer's disease (AD) and other tauopathies.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19459590", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 104, 
            "text": "Pseudohyperphosphorylation causing AD-like changes in tau has significant effects on its polymerization.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19459590", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 368, 
            "offsetInEndSection": 647, 
            "text": "In AD, kinases such as glycogen synthase kinase-3beta (GSK-3beta) are believed to be involved in the generation of hyperphosphorylated tau. However, the functional consequences of hyperphosphorylation on the microtubule binding and polymerization of tau are not well understood. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19459590", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 942, 
            "offsetInEndSection": 1161, 
            "text": "Pseudophosphorylation of tau decreases its affinity for microtubules, and pseudohyperphosphorylated forms of tau do not have significantly decreased levels of microtubule binding as compared to single and double sites. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19459590", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1396, 
            "offsetInEndSection": 1795, 
            "text": "On the basis of the observations that pseudohyperphosphorylated tau has decreased affinity for microtubules and reduced inducer-initiated rates of nucleation and polymerization, we propose that this combination could be the cause of the increased cytotoxicity of hyperphosphorylated tau in Alzheimer's disease and also explain the potentially beneficial role of tau polymerization and NFT formation.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19459590", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 131, 
            "text": "Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated in affected neurons of Alzheimer disease brain.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/7616230", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 233, 
            "text": "In several neurodegenerative diseases, including Alzheimer disease, the neuronal microtubule-associated protein tau becomes hyperphosphorylated, accumulates in the somatodendritic compartment, and aggregates into insoluble filaments.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19525898", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 113, 
            "text": "Tau is the major component of the neurofibrillar tangles that are a pathological hallmark of Alzheimers' disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10214944", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 132, 
            "text": "Aggregates of hyperphosphorylated tau protein are found in a group of diseases called tauopathies, which includes Alzheimers disease", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24788298", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 232, 
            "text": "In several neurodegenerative diseases, including Alzheimer disease, the neuronal microtubule-associated protein tau becomes hyperphosphorylated, accumulates in the somatodendritic compartment, and aggregates into insoluble filaments", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19525898", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1395, 
            "offsetInEndSection": 1792, 
            "text": "On the basis of the observations that pseudohyperphosphorylated tau has decreased affinity for microtubules and reduced inducer-initiated rates of nucleation and polymerization, we propose that this combination could be the cause of the increased cytotoxicity of hyperphosphorylated tau in Alzheimers disease and also explain the potentially beneficial role of tau polymerization and NFT formation", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19459590", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 76, 
            "offsetInEndSection": 237, 
            "text": "In the brains of individuals with Alzheimers disease, tau is hyperphosphorylated and aggregated into intraneuronal deposits called neurofibrillary tangles (NFTs)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15450610", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 153, 
            "text": "Neurofibrillary tangles and neuropil threads, both made of hyperphosphorylated tau proteins, point to an alteration of microtubules in Alzheimers disease", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/9427351", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 177, 
            "offsetInEndSection": 405, 
            "text": "Hyperphosphorylation, which diminishes the microtubule-binding capacity of tau, destabilizes microtubules and may enhance the formation of paired helical filaments that constitute neurofibrillary tangles in Alzheimer's disease. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/7666054", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 439, 
            "text": "In several neurodegenerative diseases, including Alzheimer disease, the neuronal microtubule-associated protein tau becomes hyperphosphorylated, accumulates in the somatodendritic compartment, and aggregates into insoluble filaments. The consequences of the accumulation of hyperphosphorylated tau in the somatodendritic compartment remain poorly characterized at the early stage of disease before the formation of tau insoluble filaments.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19525898", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 285, 
            "text": "Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated in affected neurons of Alzheimer disease brain. This hyperphosphorylated tau can be dephosphorylated at some of the abnormal phosphorylated sites by purified protein phosphatase-1, 2A, and 2B in vitro.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/7616230", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 404, 
            "text": "Adult human nerve cells contain tau protein, a phosphorylated microtubule-associated protein, that is hyperphosphorylated in the fetus and in patients with Alzheimer's disease. Hyperphosphorylation, which diminishes the microtubule-binding capacity of tau, destabilizes microtubules and may enhance the formation of paired helical filaments that constitute neurofibrillary tangles in Alzheimer's disease.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/7666054", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 776, 
            "offsetInEndSection": 1047, 
            "text": "Importantly, hyperphosphorylated tau comprises the paired helical filament, whose pathological deposition as neurofibrillary tangles is implicated in Alzheimer's disease; hyperphosphorylated tau is also implicated in the pathogenesis of other neurodegenerative disorders.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16793187", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 548, 
            "offsetInEndSection": 826, 
            "text": "In Alzheimer disease (AD) brain tau is ~three to four-fold more hyperphosphorylated than the normal adult brain tau and in this hyperphosphorylated state it is polymerized into paired helical filaments ([PHF) admixed with straight filaments (SF) forming neurofibrillary tangles.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20678074", 
            "endSection": "abstract"
        }
    ]
}